By collaborating with Indian Generic Medicine (IGM) as your Semaglutide Third Party Manufacturer company, you gain a trusted partner who guarantees success
Patients on microdosing protocols benefit from regular check-ins assessing appetite changes, weight trajectories, side effect profiles, and metabolic markers
Wegovy is currently indicated for patients with a BMI over 30 kg/m or a BMI over 27 kg/m with at least one weight-related medical condition
This means roughly 1 in 15 to 1 in 20 patients will develop heartburn specifically because of the medication that would not have occurred otherwise
But the dosage can vary depending on the person
Going forward: 503A pharmacies (traditional compounders) can still prepare semaglutide for individual patients with a valid prescription, when a specific medical need exists that the commercial product doesnt meet such as a patient requiring a different dose, diluent, or delivery format